[Differential therapy of cerebral angiomas].
Patients with cerebral arteriovenous malformations (cAVMs) are usually young at the time of diagnosis with a mean age of 32 years. These patients are in a crucial phase of their lives, starting a family and establishing a professional position. Facing a relative annual risk of 2 to 3% for a severe hemorrhage which cumulates to a 50% risk of hemorrhage over the next four decades of their lives, these patients have to make the decision about possible treatment of their cAVM. Advice can only be given to the patients on an individual basis because there are almost no two identical lesions. Nevertheless, based on a grading system and within established treatment regimens, risk estimations are possible and particularly with close neuroradiological/neurosurgical cooperation these risks can be defined and minimized. In this context we report a series of 184 patients with cAVMs which were taken care of at the Departments of Neurosurgery and Neuroradiology at the University of Hamburg between February 1988 and July 1996 and who were treated according to a standardized joint protocol with interventional and microsurgical options.
Grzyska
U
U
Abteilung für Neuroradiologie, Universitätskrankenhauses Eppendorf, Hamburg, Deutschland.
Neumaier Probst
E
E
Koch
C
C
Westphal
M
M
D000328:Adult; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D004621:Embolization, Therapeutic; D005260:Female; D006391:Hemangioma / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D008297:Male; D008866:Microsurgery; D010348:Patient Care Team; D011859:Radiography; D015996:Survival Rate; D016896:Treatment Outcome